Loading clinical trials...

Impact of High Flow Therapy on Complications Related to Airway Stenting | Clinical Trials | Clareo Health

UNKNOWNNA

Impact of High Flow Therapy on Complications Related to Airway Stenting

Impact of High Flow Therapy Through Nasal Cannula on Complications Related to Airway Stenting: a Prospective, Multicentric, Randomized-controlled Trial

NCT06069817•Cardarelli Hospital

View on ClinicalTrials.gov

Summary

The application of HFNC therapy in patients with airway stent, improving both humidification and clearance of the airway secretion, could potentially reduce the risk of mucoid impaction, respiratory infections and granulation. HFNC therapy could be superior to nebulization of normal saline (usual care) in order to keep the stent cleaned, reducing, by inference, the risk of complications, as defined above.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Written informed consent
•Central Airway obstruction, both malignant and nonmalignant, treated with airway stenting (silicone or fully covered metallic stent)

Exclusion Criteria

•Contraindication to HFNC (recent - within 3 months - nose surgery or facial trauma)
•Lack of written informed consent
•Neuropsychiatric disorders
•Pregnancy

Locations (1)

Interventional Pulmonology Unit, Cardarelli Hospital

Naples, Italy

Key Dates

Start Date

January 1, 2024

Primary Completion Date

November 1, 2024

Completion Date

December 31, 2024

Last Updated

February 13, 2024

Enrollment

ESTIMATED participants

Conditions

Airway ObstructionRespiratory InfectionMucus; Plug

Interventions

High flow nasal cannula

DEVICE

nebulized normal saline

DEVICE

Contacts

Nadia Corcione, MD, PhD

CONTACT

+ 39 0817473393 nadia.corcione@gmail.com

Effectiveness and Implementation of a National Guideline for Acute Respiratory Tract Infections to Reduce Antibiotic Prescribing in Swiss Primary Care

NCT07396428

Acute Respiratory InfectionInfluenza-like Illness

View study

RECRUITING

The Fever Clinic Acute Respiratory Cohort

NCT07278700

Acute Respiratory InfectionsFebrile Illnesses+3 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 13, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Impact of High Flow Therapy on Complications Related to Airway Stenting

Inclusion Criteria

Exclusion Criteria

Effectiveness and Implementation of a National Guideline for Acute Respiratory Tract Infections to Reduce Antibiotic Prescribing in Swiss Primary Care

The Fever Clinic Acute Respiratory Cohort

FebriDx® Pediatric Validation Study

Impact of the Presence of Anti-interferon Autoantibodies on the Viral Load in Severe Respiratory Infections

Omalizumab Before Onset of Exacerbations

Study of the Safety, Tolerability, and Pharmacokinetic Profile of Ascending Doses of Ingavirin Forte, Capsules, Folliwing Single and Subsequent Multiple Oral Administration in Healthy Volunteers